Home
About
Product
magNews
Career
Contact Us
中文
English
magNews
Corporate
Industry
Technology
Medical Updates
Corporate
Redefining New Boundaries in Delivering Patient Care
2025-01-24
Corporate
magAssist Recognized in 2024 VENTURE50 Awards
2025-01-09
Corporate
MoyoAssist® Extra-VAD® Introduces Fully Magnetically Levitated Extracorporeal Heart Support Technology in China
2024-06-28
Corporate
MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held
2024-06-24
2022 list of China's most socially impactful startups
Corporate
Highlights|magAssist Invited to Join VBData’s Live Stream on The Future is Now a Reality! Percutaneous Ventricular Assist Devices Fast-tracked for Clinical Application
2022-12-12
Corporate
magAssist founder Dr. Po-Lin HSU, was selected as 2022 Most Influential Business Women——Future by FORTUNE China
2022-11-03
Corporate
MoyoAssist®, the winning project for Australian Good Design Awards and Designer Australia Awards 2022.
2022-09-30
Corporate
magAssist is on the list of Forbes Asia 100 to Watch 2022
2022-09-09
Medical Updates
The FIRST transseptal cannulation treatment via MoyoAssist Extra-VAD
2022-08-24
Corporate
Fortune China recently released its 2022 list of China's most socially impactful startups, and magAssist is on the list.
2022-08-06
Corporate
magAssist named on List of 2022 Top 100 Emerging Advanced Medical Device Companies in China
2022-08-05
Corporate
magAssist partners with top universities to help nurture young talents
2022-07-16
Technology
magAssist participation in the 9th World Congress of Biomechanics 2022
2022-07-10
Corporate
Dr. Polin Hsu, has been elected as one of the 40 under 40 business elites by Fortune China.
2022-06-22
《
···
2
3
4
5
6
···
4/9
》
Tags:
Innovation,
Application,
Extra-VAD,
U.S. FDA,
Interventional Ventricular Assist Device,
Breakthrough Device,
VENTURE50,
Awards,
Healthcare,
Difference,
TOP